Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001744280-22-000001
Filing Date
2022-03-24
Accepted
2022-03-24 17:49:19
Documents
1
Period of Report
2022-03-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 17326
  Complete submission text file 0001744280-22-000001.txt   18722
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Issuer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRICIDA, INC. 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address
COUFAL SANDRA I (Reporting) CIK: 0001744280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38558 | Film No.: 22767725